Transforming growth factor-beta1 in the kidney and urine of patients with glomerular disease and proteinuria
Sotiris Tsakas
Nephrology Dialysis Transplantation, 2002
View PDFchevron_right
Transforming growth factor-β (TGF-β) activity in urine of patients with glomerulonephritis is related to their renal functional and structural changes
Marcio Dantas
Nephrology, 2008
View PDFchevron_right
Expression of TGF-beta receptors type I and II in human glomerulonephritis
S. Feriozzi
Nephrology Dialysis Transplantation, 1998
View PDFchevron_right
Divergent effects of low versus high dose anti-TGF-β antibody in puromycin aminonucleoside nephropathy in rats
Sharda Jha
Kidney International, 2004
View PDFchevron_right
Transforming growth factor- and the progression of renal disease
Gunter Wolf
Nephrology Dialysis Transplantation, 2014
View PDFchevron_right
Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats
Li-jun Ma
Kidney International, 2004
View PDFchevron_right
Accurate Measurement and Clinical Significance of Urinary Transforming Growth Factor-Beta<sub>1</sub>
Sotiris Tsakas
American Journal of Nephrology, 2006
View PDFchevron_right
Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients
Monica Ceol
Journal of nephrology
View PDFchevron_right
Urine activity of cathepsin B, collagenase and urine excretion of TGF-β 1 and fibronectin in membranous glomerulonephritis
Leszek Paczek
Research in Experimental Medicine, 1998
View PDFchevron_right
Evaluating the Serum Transforming Growth Factor-Beta 1 Level in Chronic Kidney Disease Caused by Glomerulonephritis
Elian Cruz
Nephro-Urology Monthly, 2021
View PDFchevron_right
Increased mRNA encoding for transforming factor-β in CD4+ cells from patients with IgA nephropathy
Rainbow Ho
Kidney International, 1994
View PDFchevron_right
Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo
David Roberts
Kidney International, 2004
View PDFchevron_right
Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced …
F. Ziyadeh
Diabetes
View PDFchevron_right
Increased renal production of transforming growth factor-beta1 in patients with type II diabetes
F. Ziyadeh
Diabetes, 1997
View PDFchevron_right
Study of the Urinary TGF-β1 Profile in Diabetic Nephropathy: A Single-Center Experience From India
Dr Atul Sajgure
Cureus, 2023
View PDFchevron_right
Transforming Growth Factor-β1 in Balkan Endemic Nephropathy
Danica Bukvic
Nephron Clinical Practice, 2009
View PDFchevron_right
Transforming growth factor-beta signal transduction and progressive renal disease
Joseph Grande
Experimental Biology and Medicine, 2003
View PDFchevron_right
TGF-beta signal transduction in chronic kidney disease
Sara Jandeska
Frontiers in Bioscience, 2009
View PDFchevron_right
Increased mRNA encoding for transforming factor-� in CD4+ cells from patients with IgA nephropathy
Rainbow Ho
Kidney Int, 1994
View PDFchevron_right
Acute and chronic renal effects of recombinant human TGF-��2 in the rat
Steven Ledbetter
1999
View PDFchevron_right
Analysis of Relative Expression Level of VEGF ( Vascular Endothelial Growth Factor ), HIF-1a ( Hypoxia Inducible Factor 1a ) and CTGF ( Connective Tissue Growth Factor ) Genes in Chronic Glomerulonephritis (CGN) Patients
Andrzej Marszałek, Joanna Szczepanek, Andrzej TRETYN
Kidney and Blood Pressure Research, 2013
View PDFchevron_right
Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis
Markus Bitzer
Journal of molecular medicine (Berlin, Germany), 2003
View PDFchevron_right
Transforming growth factor beta and progression of renal disease
Phyllis August
Kidney International, 2003
View PDFchevron_right
Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis
Marina Katerelos
Kidney International, 2000
View PDFchevron_right
Analysis of Relative Expression Level of VEGF ( Vascular Endothelial Growth Factor ), HIF-1α (Hypoxia Inducible Factor 1 α) and CTGF ( Connective Tissue Growth Factor ) Genes in Chronic Glomerulonephritis (CGN) Patients
Andrzej TRETYN
View PDFchevron_right
Depleted TGF-β1 levels in end stage renal disease patients from North India
Prabodh Sehajpal
2014
View PDFchevron_right
Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure
Coskun Cevher
Bratislava Medical Journal, 2017
View PDFchevron_right
Transforming growth factor-beta in renal disease with glycogen storage disease I
Shoji Kagami
Pediatric nephrology (Berlin, Germany), 2004
View PDFchevron_right
Cytokines and glomerulosclerosis
Masanori Tsujie
Nephrology Dialysis Transplantation, 1999
View PDFchevron_right
Connective tissue growth factor: just another factor in renal fibrosis?
Jan Aten
Nephrology Dialysis Transplantation, 2000
View PDFchevron_right
Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction
Muhammad Islam
Kidney International, 2001
View PDFchevron_right
Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis
grzegorz Senatorski
Research in experimental medicine. Zeitschrift für die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1998
View PDFchevron_right
Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis
Sotiris Tsakas
2005
View PDFchevron_right
Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy
Fuad Ziyadeh
Kidney International Supplement, 1995
View PDFchevron_right